Address: Bvd. Manuel Avila Camacho #36 Piso 11, C.P. 11 000 Lomas de Chapultepec Mexico D.F.,Mexico
Tel: 55.5249.7460
Web: http://www.nobelbiocare.com/es/splash/
As the pioneer in our industry, we have a long tradition of innovation and clinical excellence. We provide a leading portfolio of products and solutions to help our customers treat their patients’ needs in the best possible way. Our wide range of top-quality products can restore missing or damaged teeth from crown to root. Today, millions of people suffer from missing teeth. The penetration of implant-based tooth restorations is still very low, and such treatments offer sustainable growth potential. Furthermore, global market trends, such as changing demographics and patient demands, present attractive opportunities.
Nobel Biocare offers dental professionals a complete product portfolio that provides them with a comprehensive range of innovative and science-based restorative solutions – from tooth to root, for all indications, from a single tooth to full arches, and supported by natural teeth or implants.
Nobel Biocare is a world leader in innovative restorative and esthetic dental solutions. How is the Mexican audience responding to your products? There is a wide segment of the Mexican…
UCB’s Omar Lugo Aguirre outlines the company’s response to the COVID-19 pandemic in Mexico, countering stigmas around neurodegenerative and mental diseases, and the abundant opportunities that Mexico and the region…
Americo Garcia oversees Latin American operations for Canadian generics player Apotex. He outlines the firm’s impressive growth in the region in recent years – expanding both in terms of portfolio…
Inosan Biopharma General Manager Juan Lopez de Silanes outlines the Mexican family company’s recent milestones, including an impressive internationalisation push in the Middle East & Africa Region, how demand for…
Sara Montero, managing director of Lundbeck Mexico, Central America and Andean countries since January 2020, explains her key priorities and the importance of the region for Lundbeck, highlights the current…
Mauricio Guizar, newly appointed general manager of Ipsen Mexico since October 2019, shares his first impression of the French specialty care player’s operations in Mexico, the significance of being the…
Francisco Kuri Breña, director of new developments at local Mexican player Landsteiner, shares the company’s existing positioning as one of the top 10 suppliers of generic medicines to the Mexican…
CP Maria del Socorro España Lomeli, executive director of the Mexican generics industry association ANAFAM, discusses the challenges with regard to the ‘new rules of the game’ in Mexico’s healthcare…
Arturo Prida Romero, the president of the current National Council of the Partido de la Revolución Democrática (PRD) – one of the main political parties in Mexico – shares the…
Mario Muniz, SVP and GM of IQVIA North LATAM, shares his motivations for joining IQVIA after nearly two decades with pharma and medtech companies, the huge potential of the North…
Earlier in 2020, PharmaBoardroom sat down with several key stakeholders in the Mexican healthcare and life sciences industry, from the leaders of multinational affiliates, start-up entrepreneurs, association heads, and key…
Diego Ruiz, CEO and co-founder of Eseotr3s Pharma shares his entrepreneurial background and the motivation for establishing Eseotr3s Pharma; their focus on flexibility and quality; their international operations and network,…
Chiesi Mexico’s Marco Ruggiero discusses his initial impressions of the Mexican pharma market, his strategic priorities for the affiliate, and the increasing importance of the company’s respiratory portfolio in Mexico.…
See our Cookie Privacy Policy Here
